Journal article
Are We Prepped for Preexposure Prophylaxis (PrEP)? Provider Opinions on the Real-World Use of PrEP in the United States and Canada
Clinical infectious diseases, Vol.58(5), pp.704-712
12/06/2013
DOI: 10.1093/cid/cit796
PMCID: PMC3922214
PMID: 24319083
Abstract
We present the results of a nationwide survey regarding HIV preexposure prophylaxis (PrEP) opinions and practices of infectious diseases physicians. Providers supported PrEP, but very few had provided it. Despite CDC guidance, real-world PrEP practices were highly variable.
Background.
Preexposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine (Truvada) has demonstrated efficacy in placebo-controlled clinical trials involving men who have sex with men, high-risk heterosexuals, serodiscordant couples, and intravenous drug users. To assist in the real-world provision of PrEP, the Centers for Disease Control and Prevention (CDC) has released guidance documents for PrEP use.
Methods.
Adult infectious disease physicians were surveyed about their opinions and current practices of PrEP through the Emerging Infections Network (EIN). Geographic information systems analysis was used to map out provider responses across the United States.
Results.
Of 1175 EIN members across the country, 573 (48.8%) responded to the survey. A majority of clinicians supported PrEP but only 9% had actually provided it. Despite CDC guidance, PrEP practices were variable and clinicians reported many barriers to its real-world provision.
Conclusions.
The majority of adult infectious disease physicians across the United States and Canada support PrEP but have vast differences of opinion and practice, despite the existence of CDC guidance documents. The success of real-world PrEP will likely require multifaceted programs addressing barriers to its provision and will be assisted with the development of comprehensive guidelines for real-world PrEP.
Details
- Title: Subtitle
- Are We Prepped for Preexposure Prophylaxis (PrEP)? Provider Opinions on the Real-World Use of PrEP in the United States and Canada
- Creators
- Maile Y. Karris - University of California San DiegoSusan E. Beekmann - University of California San DiegoSanjay R. Mehta - University of California San DiegoChristy M. Anderson - University of California San DiegoPhilip M. Polgreen - Roy J. and Lucille A. Carver College of Medicine
- Resource Type
- Journal article
- Publication Details
- Clinical infectious diseases, Vol.58(5), pp.704-712
- DOI
- 10.1093/cid/cit796
- PMID
- 24319083
- PMCID
- PMC3922214
- NLM abbreviation
- Clin Infect Dis
- ISSN
- 1058-4838
- eISSN
- 1537-6591
- Publisher
- Oxford University Press
- Language
- English
- Date published
- 12/06/2013
- Academic Unit
- Infectious Diseases; Epidemiology; Injury Prevention Research Center; Internal Medicine
- Record Identifier
- 9984359592702771
Metrics
16 Record Views